Article

ARVO kicks off in the Big Easy

Author(s):

The Association for Research in Vision and Ophthalmology (ARVO) kicked off its annual meeting today at the Ernest N. Morial Convention Center in New Orleans.

An image of the Ernest N. Morial Convention Center. (Image Credit Ernest N. Morial Convention Center)

(Image Credit Ernest N. Morial Convention Center)

The Association for Research in Vision and Ophthalmology (ARVO) kicked off its annual meeting today at the Ernest N. Morial Convention Center in New Orleans, with a theme highlighting both to the mechanistic diversity in ocular disease and the different perspectives and backgrounds of the scientists involved.

Attendees will dress up for a night of charity this evening with the ARVO Foundation Gala, Hosted on the eve of the opening of ARVO 2023 on Sunday. A pre-ceremony invitation event for members of the prestigious Dowling Society, the gala recognizes individuals for their significant support for eye and vision research.

According to ARVO organizers, this evening’s semiformal dinner honors individuals and organizations for their dedication to the ARVO Foundation and its mission. This year’s theme will be The Roaring Twenties. Ticket purchase required.

The 2023 ARVO Foundation honorees include BrightFocus Foundation, honored for its philanthropic support of the Travel Grant program, the EyeFind Research Grant and the Women in Eye and Vision Research (WEAVR) initiative.

Individual honorees include Stella M. Robertson, PhD, FARVO, and W. Daniel Stamer, PhD, FARVO.

Robertson is being honored for her long-standing support of the Women in Eye and Vision Research (WEAVR) initiative and her generous philanthropic support of the Foundation.

The Foundation is recognizing Stamer for his efforts to develop the EyeFind Research Grant and his generous philanthropic support of the Foundation.

Starting Sunday, attendees will be able to enjoy paper presentations, symposia, and lectures as well as participate in discussions with presenters and representatives of leading ophthalmic manufacturers. The conference will showcase new research and provide the opportunity to network with colleagues and industry leaders.

The comprehensive program includes poster and paper presentations by up-and-coming scientists as well as renowned leaders in their fields. But the event begins even before its kickoff tomorrow.

The two-day Imaging in the Eye Conference concluded this afternoon, providing members the chance to discuss new techniques and methods for ocular imaging and its application in clinical ophthalmology, fundamental vision research, and biomedicine.

Today’s courses included full- and half-day courses on artificial intelligence, diabetic retinopathy, electrophysiologic research, electronic health records, power/sample size calculations, randomized clinical trials, registry of ophthalmic diseases, and genetic testing.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
© 2025 MJH Life Sciences

All rights reserved.